Skip to main content
. 2020 Nov 8;26:15–23. doi: 10.1016/j.ctro.2020.11.003

Fig. 5.

Fig. 5

Immunoblotting for each drug and combination with radiation in UT-SCC-14 xenografts (A) and UT-SCC-15 xenografts (B) for total and phoshorylated proteins in the PI3K pathway. Actin controls are shown for each gel (data not shown for clarity). There was n = 2 for these studies.